Lower riskDrug recall · FDA · Published December 20, 2021
American Health Packaging Metoprolol Tablets Recall: Failed Dissolution Specifications
American Health Packaging recalls 50mg Metoprolol Succinate Extended-Release Tablets due to failed dissolution specifications. This may affect medication effectiveness. Check NDC 68001-501-03 and specific lots for affected products.
“American Health Packaging Metoprolol Tablets Recall: Failed Dissolution Specifications.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35421-american-health-packaging-metoprolol-tablets-recall-failed-dissolution-specifications. Based on FDA recall #D-0451-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0451-2022%22&limit=1).
The FDA announced on December 20, 2021, that American Health Packaging is recalling Metoprolol Succinate Extended-Release Tablets, USP 50 mg due to failed dissolution specifications. The recall affects 6,637 bottles distributed nationwide.
The tablets failed dissolution specifications. The FDA classified this recall as Class II.
Context
GovInfoNow's records show American Health Packaging has 41 other recalls on record since July 23, 2012. Other recent recalls of similar products include American Health Packaging Buprenorphine Tablets Recall (August 19, 2026), American Health Packaging Nitrofurantoin Capsules Recall (May 3, 2022), and American Health Packaging Recalls Cyanocobalamin Injection (April 12, 2022). Other recent recalls of similar products include Teva Metoprolol Succinate Tablets Recall (January 29, 2026), Teva Metoprolol Succinate Extended-Release Tablets Recall (January 29, 2026), and Teva Recalls Metoprolol Succinate 50 mg (January 29, 2026).
How to tell if you have this one
Check for the NDC code 68001-501-03 on the bottle. The specific lots listed are 21141983, 21141984, 21141985 (expiring 03/31/2023) and 21142017, 21142018, 21142019 (expiring 02/28/2023).
Brand
American Health Packaging
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Look for the NDC code 68001-501-03 and the specific lots mentioned in the recall notice.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 15 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0451-2022 (December 20, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0451-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.